DOSSIER · 13F Holders · Q2 2026
PROTAGONIST THERAPEUTICS
10 institutions still hold PROTAGONIST THERAPEUTICS as of Q2 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 74366E106·10 13F holders·last filed Jun 30, 2026
AI Holders Summary · Q2 2026
10 institutions reported PROTAGONIST THERAPEUTICS in Q2 2026. SCHRODER INVESTMENT MANAGEMENT GROUP leads at 57.9% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.